Literature DB >> 22152947

Biomaterials for the treatment of myocardial infarction: a 5-year update.

Aboli A Rane1, Karen L Christman.   

Abstract

The first review on biomaterials for the treatment of myocardial infarction (MI) was written in 2006. In the last 5 years, the general approaches for biomaterial treatment of MI and subsequent left ventricular remodeling remain the same, namely, left ventricular restraints, epicardial patches, and injectable therapies. Nonetheless, there have been significant developments in this field, including advancement of biomaterial therapies to large animal pre-clinical studies and, more recently, to clinical trials. This review focuses on the progress made in the field of cardiac biomaterial treatments for MI over the last 5 years.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22152947     DOI: 10.1016/j.jacc.2011.11.001

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  82 in total

Review 1.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

2.  Cardiac fibroblast-derived 3D extracellular matrix seeded with mesenchymal stem cells as a novel device to transfer cells to the ischemic myocardium.

Authors:  Eric G Schmuck; Jacob D Mulligan; Rebecca L Ertel; Nicholas A Kouris; Brenda M Ogle; Amish N Raval; Kurt W Saupe
Journal:  Cardiovasc Eng Technol       Date:  2014-03-01       Impact factor: 2.495

Review 3.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

4.  Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle.

Authors:  J L Ungerleider; T D Johnson; N Rao; K L Christman
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

5.  A comparison of electrospun polymers reveals poly(3-hydroxybutyrate) fiber as a superior scaffold for cardiac repair.

Authors:  Delia Castellano; María Blanes; Bruno Marco; Inmaculada Cerrada; Amparo Ruiz-Saurí; Beatriz Pelacho; Miriam Araña; Jose A Montero; Vicente Cambra; Felipe Prosper; Pilar Sepúlveda
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 6.  Biomaterial applications in cardiovascular tissue repair and regeneration.

Authors:  Mai T Lam; Joseph C Wu
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-08

7.  Oxime cross-linked injectable hydrogels for catheter delivery.

Authors:  Gregory N Grover; Rebecca L Braden; Karen L Christman
Journal:  Adv Mater       Date:  2013-03-12       Impact factor: 30.849

8.  Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Authors:  Sonya B Seif-Naraghi; Jennifer M Singelyn; Michael A Salvatore; Kent G Osborn; Jean J Wang; Unatti Sampat; Oi Ling Kwan; G Monet Strachan; Jonathan Wong; Pamela J Schup-Magoffin; Rebecca L Braden; Kendra Bartels; Jessica A DeQuach; Mark Preul; Adam M Kinsey; Anthony N DeMaria; Nabil Dib; Karen L Christman
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

9.  A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro.

Authors:  Kristin M French; Archana V Boopathy; Jessica A DeQuach; Loice Chingozha; Hang Lu; Karen L Christman; Michael E Davis
Journal:  Acta Biomater       Date:  2012-07-27       Impact factor: 8.947

10.  MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.

Authors:  Shauna M Dorsey; Jeremy R McGarvey; Hua Wang; Amir Nikou; Leron Arama; Kevin J Koomalsingh; Norihiro Kondo; Joseph H Gorman; James J Pilla; Robert C Gorman; Jonathan F Wenk; Jason A Burdick
Journal:  Biomaterials       Date:  2015-08-06       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.